VSV oncolysis in combination with the BCL-2 inhibitor obatoclax overcomes apoptosis resistance in chronic lymphocytic leukemia. [electronic resource]
Producer: 20110418Description: 2094-103 p. digitalISSN:- 1525-0024
- Animals
- Antineoplastic Agents -- pharmacology
- Apoptosis
- Cell Line, Tumor
- Combined Modality Therapy
- Disease Models, Animal
- Female
- Genetic Therapy
- Humans
- Indoles
- Leukemia, Lymphocytic, Chronic, B-Cell -- therapy
- Mice
- Mice, SCID
- Proto-Oncogene Proteins c-bcl-2 -- antagonists & inhibitors
- Pyrroles -- pharmacology
- Reverse Transcriptase Polymerase Chain Reaction
- Vesiculovirus -- physiology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.